HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma.

AbstractPURPOSE:
The study aimed to analyze the expression of bone morphogenetic protein-2/4 (BMP-2/4) and its receptor BMPR-IA (BMP receptor type IA) in metastatic and nonmetastatic oral squamous cell carcinoma (OSCC) and its implications for disease prognosis.
MATERIALS AND METHODS:
The experimental group included 16 cases of OSCC without metastasis and 7 cases of OSCC with metastasis. The presence or absence of nodal metastasis was used as a parameter for the evaluation of disease prognosis. Ten cases of oral fibroepithelial hyperplasia were selected as the control group. The expression of BMP-2/4 and BMPR-IA was analyzed by immunohistochemistry.
RESULTS:
In the experimental group with metastasis, strong expression of BMP-2/4 was observed in most cases (71.4%), whereas BMPR-IA exhibited weak expression (85.7%). In the experimental group without metastasis, there was strong expression of BMP-2/4 (62.5%) and BMPR-IA (100%). A significant association was observed between the prognosis of OSCC and the intensity of BMP-2/4 staining (P = .002). Weak immunoreactivity to BMP-2/4 and BMPR-IA was observed in all control specimens.
CONCLUSIONS:
The results suggest that strong expression of BMP-2/4, associated with low expression of BMPR-IA, observed in metastatic OSCC has a prognostic value, with the loss of responsiveness to BMPs through the loss of expression of their receptors being indicative of the development of metastasis.
AuthorsAndréa Ferreira Soares, Ruth Lopes de Freitas Xavier, Márcia Cristina da Costa Miguel, Lélia Batista de Souza, Leão Pereira Pinto
JournalAmerican journal of otolaryngology (Am J Otolaryngol) 2010 Jul-Aug Vol. 31 Issue 4 Pg. 266-71 ISSN: 1532-818X [Electronic] United States
PMID20015767 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright 2010. Published by Elsevier Inc.
Chemical References
  • Biomarkers, Tumor
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein Receptors, Type I
Topics
  • Biomarkers, Tumor (biosynthesis)
  • Bone Morphogenetic Protein 4 (biosynthesis)
  • Bone Morphogenetic Protein Receptors, Type I (biosynthesis)
  • Carcinoma, Squamous Cell (metabolism, secondary)
  • Disease Progression
  • Humans
  • Immunohistochemistry
  • Mouth Neoplasms (metabolism, pathology)
  • Neoplasm Metastasis
  • Prognosis
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: